Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.19 trillion and total revenue of $109.89 billion.
Market Cap
1.19T
Revenue
109.89B
Profits
-41.55B
PE Ratio
n/a
Profit Margin
-37.81%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 118.82B | 0.29% | 120,996 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.68B | 0.58% | 120,163 | 14.92B |
| 3 | ARGX | argenx SE | 56.65B | 2.03% | 69,077 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.21B | -0.07% | 151,467 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 36.23B | 2.79% | 469,520 | - |
| 6 | RPRX | Royalty Pharma plc | 31.35B | 1.64% | 392,943 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 30.46B | 0.81% | 29,896 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 25.28B | 7.34% | 1,943,160 | 2.23B |
| 9 | BNTX | BioNTech SE | 23.12B | 1.39% | 48,777 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 22.58B | 0.45% | 708,117 | 8.26M |
| 11 | INSM | Insmed Incorporated | 21.61B | 1.11% | 633,734 | 819.56M |
| 12 | INCY | Incyte Corporation | 20.79B | 0.38% | 138,310 | 5.36B |
| 13 | GMAB | Genmab A/S | 15.56B | 1.52% | 440,022 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.46B | 2.08% | 172,135 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.14B | -0.26% | 55,611 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.59B | 0.65% | 334,835 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 12.86B | -0.35% | 304,645 | 2.38B |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12.86B | 0.82% | 128,770 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.61B | 0.57% | 164,735 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.96B | 1.17% | 27,292 | 1.13B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.55B | - | 123,507 | 622.01M |
| 22 | SMMT | Summit Therapeutics Inc. | 11.28B | 1.75% | 1,232,816 | - |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.95B | 1.36% | 147,996 | 3.24B |
| 24 | CYTK | Cytokinetics, Incorporated | 10.90B | 1.40% | 281,921 | 105.82M |
| 25 | KRYS | Krystal Biotech, Inc. | 10.15B | 0.29% | 41,087 | 417.30M |
| 26 | APGE | Apogee Therapeutics, Inc. | 9.94B | 0.09% | 2,991,848 | - |
| 27 | NUVL | Nuvalent, Inc. | 9.75B | 0.05% | 280,540 | - |
| 28 | TECH | Bio-Techne Corporation | 8.91B | 2.37% | 151,973 | 1.21B |
| 29 | CORT | Corcept Therapeutics Incorporated | 8.80B | 2.85% | 112,138 | 769.10M |
| 30 | SYRE | Spyre Therapeutics, Inc. | 8.73B | 0.21% | 304,705 | - |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 8.53B | 0.83% | 41,857 | 7.46M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 8.26B | 1.00% | 147,019 | 1.51B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 8.15B | -0.37% | 469,202 | 51.48M |
| 34 | IMVT | Immunovant, Inc. | 7.92B | 1.31% | 161,404 | - |
| 35 | IBRX | ImmunityBio, Inc. | 7.83B | 3.53% | 3,239,185 | 140.98M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.83B | -1.69% | 284,983 | 5.67M |
| 37 | TGTX | TG Therapeutics, Inc. | 7.79B | 1.10% | 402,688 | 700.35M |
| 38 | PCVX | Vaxcyte, Inc. | 7.65B | 1.71% | 205,301 | - |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 7.57B | 2.36% | 81,041 | 74.06M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.97B | 0.34% | 140,628 | 217.17M |
| 41 | PTCT | PTC Therapeutics, Inc. | 6.86B | 2.16% | 613,859 | 827.11M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.47B | -1.62% | 87,125 | 569.61M |
| 43 | CNTA | Centessa Pharmaceuticals plc | 6.22B | -0.01% | 3,987,029 | 15.00M |
| 44 | COGT | Cogent Biosciences, Inc. | 6.15B | 0.33% | 724,267 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.08B | 3.10% | 152,767 | - |
| 46 | BLTE | Belite Bio, Inc | 5.85B | 1.07% | 16,118 | - |
| 47 | CGON | CG Oncology, Inc. | 5.78B | -1.09% | 81,017 | 5.07M |
| 48 | LEGN | Legend Biotech Corporation | 5.58B | 2.39% | 564,447 | 1.14B |
| 49 | CRSP | CRISPR Therapeutics AG | 5.36B | 2.28% | 276,223 | 4.10M |
| 50 | LGND | Ligand Pharmaceuticals Incorporated | 5.36B | 2.05% | 553,722 | 274.48M |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.32B | 0.47% | 111,483 | 7.50M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.16B | 0.19% | 197,072 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.13B | 0.16% | 201,341 | 536.20M |
| 54 | CAI | Caris Life Sciences, Inc. | 4.95B | 1.10% | 350,966 | 907.29M |
| 55 | ERAS | Erasca, Inc. | 4.83B | 3.08% | 700,094 | - |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.82B | 0.95% | 139,906 | 1.34M |
| 57 | CELC | Celcuity Inc. | 4.43B | 0.98% | 103,182 | - |
| 58 | MANE | Veradermics, Incorporated | 4.39B | 2.20% | 40,489 | - |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.16B | 0.91% | 816,884 | 56.99M |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.08B | 8.65% | 1,286,048 | - |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.08B | 3.81% | 93,747 | - |
| 62 | DFTX | Definium Therapeutics, Inc. | 4.05B | 1.34% | 1,635,867 | - |
| 63 | DNLI | Denali Therapeutics Inc. | 3.93B | 3.08% | 237,986 | - |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.85B | 1.77% | 163,805 | 1.10B |
| 65 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.84B | 3.04% | 68,627 | 18.07M |
| 66 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.03% | 144,742 | 596.96M |
| 67 | RLAY | Relay Therapeutics, Inc. | 3.83B | 1.62% | 341,867 | 10.68M |
| 68 | NAMS | NewAmsterdam Pharma Company N.V. | 3.64B | 1.10% | 105,009 | 22.57M |
| 69 | BEAM | Beam Therapeutics Inc. | 3.61B | 2.14% | 754,519 | 164.01M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.56B | 3.07% | 429,384 | - |
| 71 | PBLS | Parabilis Medicines, Inc. | 3.55B | 1.29% | 132,722 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.51B | 2.59% | 211,838 | 236.00M |
| 73 | TLX | Telix Pharmaceuticals Limited | 3.46B | 1.80% | 12,546 | 803.79M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | 0.19% | 229,117 | 415.62M |
| 75 | GPCR | Structure Therapeutics Inc. | 3.28B | 1.52% | 106,123 | - |
| 76 | ALMS | Alumis Inc. | 3.16B | 0.73% | 190,365 | 8.40M |
| 77 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | 2.25% | 390,312 | 225.27M |
| 78 | QURE | uniQure N.V. | 3.01B | 7.55% | 734,033 | 18.09M |
| 79 | KLRA | Kailera Therapeutics, Inc. | 2.87B | -3.19% | 68,544 | - |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.87B | 2.48% | 303,576 | - |
| 81 | RARE | Ultragenyx Pharmaceutical Inc. | 2.86B | 0.22% | 145,434 | 670.00M |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 2.79B | 2.01% | 177,543 | 535.08M |
| 83 | IRON | Disc Medicine, Inc. | 2.74B | 1.34% | 85,209 | - |
| 84 | VERA | Vera Therapeutics, Inc. | 2.73B | -1.20% | 241,819 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.63B | 0.24% | 134,955 | 865.00K |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.49B | -1.02% | 140,248 | - |
| 87 | KOD | Kodiak Sciences Inc. | 2.34B | 2.24% | 74,206 | - |
| 88 | PHVS | Pharvaris N.V. | 2.32B | 0.55% | 7,753 | - |
| 89 | BHVN | Biohaven Ltd. | 2.29B | -1.74% | 448,403 | - |
| 90 | NKTR | Nektar Therapeutics | 2.26B | 1.83% | 160,429 | 55.63M |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.24B | -0.86% | 482,527 | 298.30M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.23B | 2.11% | 580,977 | 52.04M |
| 93 | NTLA | Intellia Therapeutics, Inc. | 2.22B | 0.83% | 855,857 | 66.09M |
| 94 | IMNM | Immunome, Inc. | 2.19B | 0.86% | 69,999 | 4.02M |
| 95 | MLYS | Mineralys Therapeutics, Inc. | 2.14B | 2.44% | 197,017 | - |
| 96 | MBX | MBX Biosciences, Inc. | 2.12B | 1.57% | 106,066 | - |
| 97 | AGIO | Agios Pharmaceuticals, Inc. | 2.12B | 1.51% | 72,128 | 66.05M |
| 98 | ZLAB | Zai Lab Limited | 2.10B | 1.14% | 759,973 | 453.28M |
| 99 | NUVB | Nuvation Bio Inc. | 2.08B | 3.91% | 776,425 | 143.05M |
| 100 | VCEL | Vericel Corporation | 2.06B | -0.47% | 38,122 | 292.09M |
| 101 | KARD | Kardigan, Inc. | 2.05B | 0.99% | 38,612 | - |
| 102 | STOK | Stoke Therapeutics, Inc. | 1.99B | 3.29% | 367,231 | 32.08M |
| 103 | ADMA | ADMA Biologics, Inc. | 1.98B | -0.29% | 424,150 | 509.86M |
| 104 | GENB | Generate Biomedicines, Inc. | 1.98B | -3.02% | 98,557 | 30.30M |
| 105 | MESO | Mesoblast Limited | 1.97B | -0.87% | 15,660 | 65.38M |
| 106 | TSHA | Taysha Gene Therapies, Inc. | 1.96B | 4.44% | 269,303 | 7.47M |
| 107 | NRIX | Nurix Therapeutics, Inc. | 1.95B | 1.18% | 79,287 | 71.78M |
| 108 | IOVA | Iovance Biotherapeutics, Inc. | 1.95B | 7.64% | 4,375,616 | 285.61M |
| 109 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 0.45% | 46,479 | 899.11M |
| 110 | PGEN | Precigen, Inc. | 1.94B | 1.30% | 840,578 | 31.60M |
| 111 | VRDN | Viridian Therapeutics, Inc. | 1.92B | -1.13% | 250,861 | 70.92M |
| 112 | LKFT | Lakefront Biotherapeutics NV | 1.88B | -0.28% | 42,163 | 1.20B |
| 113 | SRPT | Sarepta Therapeutics, Inc. | 1.83B | -1.59% | 330,033 | 2.18B |
| 114 | RAPP | Rapport Therapeutics, Inc. | 1.82B | -0.13% | 10,398 | 20.00M |
| 115 | TYRA | Tyra Biosciences, Inc. | 1.82B | 1.71% | 101,045 | - |
| 116 | SION | Sionna Therapeutics, Inc. | 1.80B | 2.81% | 77,153 | - |
| 117 | ABCL | AbCellera Biologics Inc. | 1.78B | 1.74% | 941,411 | 79.21M |
| 118 | ANAB | AnaptysBio, Inc. | 1.78B | 2.15% | 80,078 | 232.39M |
| 119 | NBTX | Nanobiotix S.A. | 1.76B | 3.04% | 16,452 | 38.27M |
| 120 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | 2.90% | 123,495 | 217.17M |
| 121 | CAPR | Capricor Therapeutics, Inc. | 1.74B | 2.15% | 82,988 | 11.13M |
| 122 | ZYME | Zymeworks Inc. | 1.73B | 2.06% | 146,149 | 81.26M |
| 123 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | 1.89% | 3,216,679 | 66.41M |
| 124 | INVA | Innoviva, Inc. | 1.72B | 2.59% | 55,657 | 420.69M |
| 125 | PVLA | Palvella Therapeutics, Inc. | 1.71B | 0.56% | 27,982 | - |
| 126 | URGN | UroGen Pharma Ltd. | 1.71B | 0.06% | 56,521 | 140.49M |
| 127 | SLS | SELLAS Life Sciences Group, Inc. | 1.68B | 5.63% | 2,385,163 | - |
| 128 | VIR | Vir Biotechnology, Inc. | 1.67B | 3.66% | 245,952 | 65.50M |
| 129 | BCAX | Bicara Therapeutics Inc. | 1.65B | 2.59% | 113,398 | - |
| 130 | GLUE | Monte Rosa Therapeutics, Inc. | 1.64B | 3.83% | 108,696 | 42.95M |
| 131 | SEPN | Septerna, Inc. | 1.61B | 2.21% | 20,729 | 72.26M |
| 132 | AVBP | ArriVent BioPharma, Inc. | 1.60B | 5.02% | 82,994 | - |
| 133 | MLTX | MoonLake Immunotherapeutics | 1.59B | -2.53% | 300,126 | - |
| 134 | NVAX | Novavax, Inc. | 1.57B | 5.89% | 1,075,446 | 596.34M |
| 135 | ARDX | Ardelyx, Inc. | 1.56B | -0.94% | 475,939 | 427.68M |
| 136 | GHRS | GH Research PLC | 1.55B | 2.35% | 57,003 | - |
| 137 | ATAI | AtaiBeckley Inc. | 1.55B | 3.70% | 1,163,076 | 3.49M |
| 138 | IMCR | Immunocore Holdings plc | 1.51B | 1.12% | 89,133 | 412.81M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.50B | 1.70% | 115,741 | 2.71B |
| 140 | DMRA | Damora Therapeutics, Inc. | 1.48B | 0.80% | 39,980 | - |
| 141 | AAPG | Ascentage Pharma Group International | 1.48B | -0.18% | 5,066 | 82.08M |
| 142 | SVRA | Savara Inc. | 1.47B | 1.76% | 211,304 | - |
| 143 | MAZE | Maze Therapeutics, Inc. | 1.44B | 1.84% | 71,613 | 20.00M |
| 144 | INBX | Inhibrx Biosciences, Inc. | 1.42B | 3.53% | 58,092 | 1.30M |
| 145 | AKTS | Aktis Oncology, Inc. | 1.42B | 3.35% | 31,357 | 8.28M |
| 146 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.40B | 3.05% | 209,686 | 204.73M |
| 147 | COAG | Hemab Therapeutics Holdings, Inc. | 1.36B | -2.76% | 15,139 | - |
| 148 | MPLT | MapLight Therapeutics, Inc. | 1.36B | 0.62% | 34,877 | - |
| 149 | IMTX | Immatics N.V. | 1.36B | 1.64% | 31,647 | 43.00M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.35B | -2.34% | 39,109 | - |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.34B | 1.68% | 38,930 | 10.00M |
| 152 | ABSI | Absci Corporation | 1.24B | -5.24% | 1,322,969 | 1.84M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.22B | 5.55% | 128,201 | - |
| 154 | MNKD | MannKind Corporation | 1.20B | 0.26% | 389,813 | 360.78M |
| 155 | WVE | Wave Life Sciences Ltd. | 1.19B | 0.24% | 505,876 | 71.80M |
| 156 | EYPT | EyePoint, Inc. | 1.19B | 3.06% | 175,304 | 7.61M |
| 157 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | 3.55% | 272,521 | - |
| 158 | MGTX | MeiraGTx Holdings plc | 1.09B | 2.70% | 112,671 | 79.76M |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 1.08B | 2.55% | 139,775 | - |
| 160 | XNCR | Xencor, Inc. | 1.06B | 2.43% | 152,049 | 97.36M |
| 161 | SANA | Sana Biotechnology, Inc. | 1.03B | 2.68% | 710,748 | - |
| 162 | SPRY | ARS Pharmaceuticals, Inc. | 1.01B | 1.70% | 199,175 | 98.99M |
| 163 | SPTX | Seaport Therapeutics, Inc. | 988.17M | 2.61% | 9,947 | - |
| 164 | REPL | Replimune Group, Inc. | 985.09M | 6.71% | 713,754 | - |
| 165 | LXRX | Lexicon Pharmaceuticals, Inc. | 963.91M | 0.93% | 494,949 | 69.64M |
| 166 | AVTX | Avalo Therapeutics, Inc. | 947.23M | 5.50% | 371,725 | 59.00K |
| 167 | DBVT | DBV Technologies S.A. | 942.13M | 5.61% | 77,076 | 5.74M |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 939.94M | 1.68% | 238,732 | - |
| 169 | KURA | Kura Oncology, Inc. | 933.91M | 1.54% | 352,844 | 71.64M |
| 170 | PHAR | Pharming Group N.V. | 917.37M | 5.27% | 5,356 | 369.49M |
| 171 | JANX | Janux Therapeutics, Inc. | 906.23M | 3.63% | 81,544 | 13.73M |
| 172 | OLMA | Olema Pharmaceuticals, Inc. | 896.19M | 2.60% | 463,091 | - |
| 173 | DRTS | Alpha Tau Medical Ltd. | 890.94M | -1.50% | 149,765 | - |
| 174 | ABUS | Arbutus Biopharma Corporation | 890.90M | -0.22% | 679,267 | 191.45M |
| 175 | SLDB | Solid Biosciences Inc. | 878.17M | 7.47% | 381,689 | - |
| 176 | DSGN | Design Therapeutics, Inc. | 876.90M | 2.48% | 70,594 | - |
| 177 | TBPH | Theravance Biopharma, Inc. | 873.31M | 2.29% | 76,612 | 109.78M |
| 178 | LBRX | LB Pharmaceuticals Inc | 864.74M | 0.95% | 67,640 | - |
| 179 | ANNX | Annexon, Inc. | 861.81M | 4.37% | 298,750 | - |
| 180 | PHAT | Phathom Pharmaceuticals, Inc. | 858.64M | 1.12% | 118,392 | 204.89M |
| 181 | GERN | Geron Corporation | 850.02M | -1.12% | 1,843,054 | 196.12M |
| 182 | EVMN | Evommune, Inc. | 839.95M | 3.41% | 79,629 | 10.00M |
| 183 | ODTX | Odyssey Therapeutics, Inc. | 836.40M | -5.29% | 31,541 | 1.06M |
| 184 | ANRO | Alto Neuroscience, Inc. | 816.64M | 1.48% | 16,355 | - |
| 185 | VOR | Vor Biopharma Inc. | 814.96M | 0.67% | 166,799 | - |
| 186 | AURA | Aura Biosciences, Inc. | 781.47M | 1.94% | 45,817 | - |
| 187 | ZVRA | Zevra Therapeutics, Inc. | 760.22M | 1.66% | 175,477 | 122.29M |
| 188 | OMER | Omeros Corporation | 744.74M | -0.39% | 135,908 | 9.89M |
| 189 | ALLO | Allogene Therapeutics, Inc. | 742.08M | 2.38% | 695,280 | 22.00K |
| 190 | RLMD | Relmada Therapeutics, Inc. | 724.79M | 0.29% | 179,808 | - |
| 191 | IVA | Inventiva S.A. | 714.31M | 3.70% | 840,911 | 7.94M |
| 192 | IMMX | Immix Biopharma, Inc. | 711.90M | 6.38% | 281,096 | - |
| 193 | CLYM | Climb Bio, Inc. | 710.60M | 1.89% | 93,091 | - |
| 194 | OCS | Oculis Holding AG | 707.14M | 0.34% | 47,927 | 1.40M |
| 195 | ACRS | Aclaris Therapeutics, Inc. | 702.51M | 3.93% | 183,032 | 8.37M |
| 196 | CRMD | CorMedix Inc. | 701.75M | 1.42% | 220,336 | 400.05M |
| 197 | CTMX | CytomX Therapeutics, Inc. | 677.06M | 2.30% | 307,816 | 35.54M |
| 198 | CADL | Candel Therapeutics, Inc. | 675.55M | 0.77% | 386,939 | - |
| 199 | RIGL | Rigel Pharmaceuticals, Inc. | 671.44M | 1.57% | 70,652 | 299.77M |
| 200 | TRAX | First Tracks Biotherapeutics, Inc. | 662.61M | 3.66% | 61,684 | - |
| 201 | SGP | SpyGlass Pharma, Inc. | 655.33M | 1.37% | 7,617 | - |
| 202 | TENX | Tenax Therapeutics, Inc. | 653.97M | 4.49% | 141,758 | - |
| 203 | SLBT | SL Science Holding Limited | 638.42M | -12.61% | 100,638 | - |
| 204 | PRME | Prime Medicine, Inc. | 637.58M | 4.75% | 732,277 | 4.03M |
| 205 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 636.85M | 1.02% | 62,325 | - |
| 206 | DRUG | Bright Minds Biosciences Inc. | 618.56M | 3.61% | 29,855 | - |
| 207 | DNA | Ginkgo Bioworks Holdings, Inc. | 604.25M | 2.32% | 275,785 | 151.40M |
| 208 | AGMB | AgomAb Therapeutics NV | 599.35M | 2.79% | 15,078 | - |
| 209 | TECX | Tectonic Therapeutic, Inc. | 588.34M | 2.77% | 18,336 | - |
| 210 | CBIO | Crescent Biopharma, Inc. | 579.85M | -0.68% | 17,920 | 11.88M |
| 211 | ALT | Altimmune, Inc. | 577.59M | 1.37% | 734,684 | 36.00K |
| 212 | FDMT | 4D Molecular Therapeutics, Inc. | 572.95M | 5.18% | 253,559 | 88.24M |
| 213 | GYRE | Gyre Therapeutics, Inc. | 568.52M | 1.50% | 13,325 | 117.05M |
| 214 | PROK | ProKidney Corp. | 558.81M | 1.65% | 114,422 | 889.00K |
| 215 | MDXG | MiMedx Group, Inc. | 552.59M | 1.09% | 106,035 | 389.42M |
| 216 | EIKN | Eikon Therapeutics, Inc. | 547.88M | 5.20% | 46,551 | - |
| 217 | RZLT | Rezolute, Inc. | 545.32M | 1.36% | 412,168 | - |
| 218 | STRO | Sutro Biopharma, Inc. | 536.22M | 2.57% | 48,140 | 99.61M |
| 219 | XOMA | XOMA Royalty Corporation | 526.41M | -0.06% | 16,403 | 48.56M |
| 220 | ASMB | Assembly Biosciences, Inc. | 516.93M | 3.72% | 41,743 | 71.10M |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 516.15M | 2.29% | 73,297 | - |
| 222 | ACHV | Achieve Life Sciences, Inc. | 512.27M | -2.16% | 352,587 | - |
| 223 | ARVN | Arvinas, Inc. | 510.36M | 2.20% | 124,467 | 89.40M |
| 224 | NGNE | Neurogene Inc. | 506.77M | -0.56% | 19,080 | 925.00K |
| 225 | CABA | Cabaletta Bio, Inc. | 504.65M | 2.82% | 497,352 | - |
| 226 | MNPR | Monopar Therapeutics Inc. | 502.81M | 9.32% | 56,199 | - |
| 227 | VALN | Valneva SE | 500.27M | 0.19% | 443 | 180.25M |
| 228 | RGNX | REGENXBIO Inc. | 499.40M | 6.50% | 637,308 | 87.82M |
| 229 | PRTA | Prothena Corporation plc | 496.05M | 3.55% | 61,975 | 57.94M |
| 230 | CCCC | C4 Therapeutics, Inc. | 494.24M | 8.50% | 950,060 | 34.86M |
| 231 | ARTV | Artiva Biotherapeutics, Inc. | 476.16M | 4.70% | 108,676 | 251.00K |
| 232 | OCGN | Ocugen, Inc. | 472.24M | 8.14% | 1,191,274 | 4.47M |
| 233 | NVCT | Nuvectis Pharma, Inc. | 450.67M | 2.78% | 41,788 | - |
| 234 | FBRX | Forte Biosciences, Inc. | 446.68M | - | 102,094 | - |
| 235 | SGMT | Sagimet Biosciences Inc. | 444.00M | 1.27% | 113,891 | - |
| 236 | CTNM | Contineum Therapeutics, Inc. | 442.47M | 1.85% | 22,531 | - |
| 237 | ANL | Adlai Nortye Ltd. | 440.40M | 5.87% | 9,905 | 5.00M |
| 238 | EDIT | Editas Medicine, Inc. | 438.13M | 1.96% | 530,532 | 38.69M |
| 239 | PRLD | Prelude Therapeutics Incorporated | 435.39M | 1.62% | 16,814 | 16.72M |
| 240 | EPRX | Eupraxia Pharmaceuticals Inc. | 432.67M | -2.71% | 301,873 | - |
| 241 | INDP | Indaptus Therapeutics, Inc. | 432.59M | 1.19% | 19,494 | - |
| 242 | BNTC | Benitec Biopharma Inc. | 427.37M | 1.14% | 19,912 | - |
| 243 | IPSC | Century Therapeutics, Inc. | 425.64M | 2.61% | 262,791 | 109.16M |
| 244 | OVID | Ovid Therapeutics Inc. | 424.61M | 1.11% | 315,468 | 7.12M |
| 245 | AUTL | Autolus Therapeutics plc | 421.84M | 6.38% | 169,560 | 92.62M |
| 246 | VTVT | vTv Therapeutics Inc. | 421.80M | 0.21% | 2,499 | 36.84M |
| 247 | STTK | Shattuck Labs, Inc. | 418.68M | 4.20% | 113,057 | 1.00M |
| 248 | ZURA | Zura Bio Limited | 406.59M | 1.18% | 147,261 | - |
| 249 | PBYI | Puma Biotechnology, Inc. | 404.14M | 3.66% | 56,465 | 227.18M |
| 250 | LXEO | Lexeo Therapeutics, Inc. | 402.82M | 1.79% | 195,998 | - |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 398.08M | 2.39% | 158,140 | 69.21M |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 398.03M | 2.43% | 36,375 | 9.01M |
| 253 | LRMR | Larimar Therapeutics, Inc. | 390.39M | 2.19% | 338,636 | - |
| 254 | RCKT | Rocket Pharmaceuticals, Inc. | 388.73M | 2.89% | 255,183 | - |
| 255 | VSTM | Verastem, Inc. | 385.77M | 3.29% | 437,581 | 49.59M |
| 256 | CMPX | Compass Therapeutics, Inc. | 374.58M | -0.95% | 393,806 | 850.00K |
| 257 | VNDA | Vanda Pharmaceuticals Inc. | 365.02M | 1.17% | 140,531 | 217.78M |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 361.32M | 2.85% | 13,807 | - |
| 259 | UPB | Upstream Bio, Inc. | 351.01M | 2.38% | 48,158 | 3.32M |
| 260 | GLSI | Greenwich LifeSciences, Inc. | 350.81M | 0.63% | 19,905 | - |
| 261 | SLN | Silence Therapeutics plc | 349.77M | -1.66% | 25,019 | 839.00K |
| 262 | IRD | Opus Genetics, Inc. | 345.93M | 4.17% | 121,974 | 11.98M |
| 263 | PALI | Palisade Bio, Inc. | 341.95M | 7.07% | 343,430 | - |
| 264 | OABI | OmniAb, Inc. | 338.51M | 0.65% | 93,020 | 28.94M |
| 265 | FENC | Fennec Pharmaceuticals Inc. | 335.56M | 1.36% | 12,070 | 51.00M |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 335.15M | 5.60% | 28,648 | - |
| 267 | ABEO | Abeona Therapeutics Inc. | 333.42M | 1.74% | 173,671 | 14.54M |
| 268 | LCTX | Lineage Cell Therapeutics, Inc. | 320.35M | 1.98% | 221,940 | 14.78M |
| 269 | ELDN | Eledon Pharmaceuticals, Inc. | 318.87M | 8.27% | 733,793 | - |
| 270 | RNAC | Cartesian Therapeutics, Inc. | 317.32M | 8.54% | 64,860 | 1.78M |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 316.99M | 1.09% | 126,676 | 1.00 |
| 272 | MGNX | MacroGenics, Inc. | 304.47M | 4.59% | 359,268 | 157.08M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 304.33M | 1.27% | 109,778 | 114.70K |
| 274 | NAUT | Nautilus Biotechnology, Inc. | 303.08M | 3.25% | 65,985 | - |
| 275 | IMRX | Immuneering Corporation | 296.31M | 3.15% | 204,453 | - |
| 276 | NMRA | Neumora Therapeutics, Inc. | 290.90M | 2.61% | 131,773 | - |
| 277 | IFRX | InflaRx N.V. | 288.69M | 3.16% | 111,194 | 33.82K |
| 278 | BCYC | Bicycle Therapeutics plc | 284.83M | 2.51% | 84,732 | 63.50M |
| 279 | LYEL | Lyell Immunopharma, Inc. | 283.98M | 1.67% | 11,800 | 31.00K |
| 280 | CNXU | Conexeu Sciences Inc. | 281.00M | -8.70% | 9,938 | - |
| 281 | SRZN | Surrozen, Inc. | 274.59M | -0.04% | 15,998 | 7.49M |
| 282 | IVVD | Invivyd, Inc. | 274.49M | 1.89% | 149,182 | 55.87M |
| 283 | NAGE | Niagen Bioscience, Inc. | 272.56M | 0.15% | 51,330 | 130.42M |
| 284 | ZNTL | Zentalis Pharmaceuticals, Inc. | 266.24M | 1.91% | 153,477 | 26.87M |
| 285 | TRDA | Entrada Therapeutics, Inc. | 263.94M | 3.60% | 28,145 | 5.74M |
| 286 | FATE | Fate Therapeutics, Inc. | 261.09M | 4.19% | 679,338 | 6.32M |
| 287 | ADAG | Adagene Inc. | 256.36M | 1.04% | 16,418 | 7.67M |
| 288 | FULC | Fulcrum Therapeutics, Inc. | 255.21M | 1.59% | 277,317 | 80.00M |
| 289 | FHTX | Foghorn Therapeutics Inc. | 254.82M | 3.83% | 11,155 | 28.22M |
| 290 | ARMP | Armata Pharmaceuticals, Inc. | 253.30M | 0.44% | 25,173 | 5.20M |
| 291 | ACIU | AC Immune SA | 252.96M | 2.00% | 29,466 | 4.62M |
| 292 | HELP | Cybin Inc. | 247.18M | 1.86% | 64,866 | - |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 246.71M | 0.98% | 12,594 | 32.72M |
| 294 | AVXL | Anavex Life Sciences Corp. | 246.51M | 4.72% | 192,998 | - |
| 295 | TARA | Protara Therapeutics, Inc. | 234.09M | 1.34% | 52,598 | - |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 233.21M | -3.33% | 4,991 | 18.47M |
| 297 | WHWK | Whitehawk Therapeutics, Inc. | 232.34M | -3.14% | 32,377 | 7.15M |
| 298 | CHRS | Coherus Oncology, Inc. | 231.37M | 1.35% | 105,895 | 46.88M |
| 299 | VYGR | Voyager Therapeutics, Inc. | 227.18M | 1.08% | 68,999 | 36.49M |
| 300 | KROS | Keros Therapeutics, Inc. | 226.22M | 4.10% | 36,274 | 33.18M |
| 301 | ALXO | ALX Oncology Holdings Inc. | 226.07M | 3.07% | 141,281 | - |
| 302 | RNA | Atrium Therapeutics, Inc. | 223.57M | 1.00% | 44,820 | 36.68M |
| 303 | NGEN | NervGen Pharma Corp. | 223.03M | -1.87% | 447,044 | - |
| 304 | CDXS | Codexis, Inc. | 221.33M | 2.74% | 62,001 | 78.09M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 220.94M | 1.31% | 4,508 | 3.93M |
| 306 | NKTX | Nkarta, Inc. | 218.57M | 9.50% | 162,467 | - |
| 307 | OTLK | Outlook Therapeutics, Inc. | 217.55M | -1.64% | 3,491,070 | 333.14K |
| 308 | NERV | Minerva Neurosciences, Inc. | 216.64M | -0.21% | 7,016 | - |
| 309 | UNCY | Unicycive Therapeutics, Inc. | 215.20M | 2.41% | 354,965 | - |
| 310 | QTTB | Q32 Bio Inc. | 211.11M | -1.58% | 62,725 | 53.74M |
| 311 | CNTN | Canton Strategic Holdings, Inc. | 209.41M | -6.54% | 203,427 | - |
| 312 | ARCT | Arcturus Therapeutics Holdings Inc. | 208.48M | 1.45% | 45,549 | 54.71M |
| 313 | KPTI | Karyopharm Therapeutics Inc. | 208.39M | 2.17% | 49,173 | 151.12M |
| 314 | IMUX | Immunic, Inc. | 207.18M | 3.12% | 34,223 | - |
| 315 | KRRO | Korro Bio, Inc. | 205.67M | 2.59% | 128,775 | 3.84M |
| 316 | ALEC | Alector, Inc. | 204.84M | 3.65% | 85,887 | 18.42M |
| 317 | GALT | Galectin Therapeutics Inc. | 204.81M | 11.07% | 247,610 | - |
| 318 | CLLS | Cellectis S.A. | 203.56M | 1.42% | 1,503 | 75.11M |
| 319 | PRQR | ProQR Therapeutics N.V. | 200.72M | 1.33% | 269,436 | 15.73M |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 199.26M | 2.46% | 114,657 | 17.56M |
| 321 | CGEN | Compugen Ltd. | 197.49M | 0.87% | 41,860 | 72.66M |
| 322 | ANTX | AN2 Therapeutics, Inc. | 188.36M | -3.15% | 56,174 | - |
| 323 | NBP | NovaBridge Biosciences | 186.19M | 5.23% | 158,849 | - |
| 324 | EQ | Equillium, Inc. | 185.25M | 2.45% | 27,061 | 4.39M |
| 325 | LENZ | LENZ Therapeutics, Inc. | 184.68M | 1.20% | 115,287 | 20.99M |
| 326 | DTIL | Precision BioSciences, Inc. | 184.49M | 0.99% | 66,348 | 45.07M |
| 327 | MIST | Milestone Pharmaceuticals Inc. | 183.67M | 3.05% | 872,466 | 1.78M |
| 328 | MDWD | MediWound Ltd. | 183.14M | 2.08% | 14,963 | 14.48M |
| 329 | OKUR | OnKure Therapeutics, Inc. | 181.38M | 1.13% | 72,431 | - |
| 330 | PLX | Protalix BioTherapeutics, Inc. | 178.47M | 2.55% | 87,257 | 76.38M |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 177.68M | 2.50% | 68,916 | - |
| 332 | YDES | YD Bio Limited | 176.50M | -10.04% | 414,114 | 510.36K |
| 333 | HURA | TuHURA Biosciences, Inc. | 174.17M | 0.92% | 335,741 | - |
| 334 | IPHA | Innate Pharma S.A. | 173.31M | - | 975 | 10.57M |
| 335 | TTRX | Turn Therapeutics Inc. | 171.28M | -0.35% | 3,459 | - |
| 336 | ORMP | Oramed Pharmaceuticals Inc. | 170.25M | 3.74% | 70,005 | 2.00M |
| 337 | CRBU | Caribou Biosciences, Inc. | 168.61M | 3.66% | 384,369 | 11.20M |
| 338 | KZIA | Kazia Therapeutics Limited | 165.12M | 3.21% | 11,616 | 1.27M |
| 339 | HUMA | Humacyte, Inc. | 164.92M | -11.50% | 10,094,309 | 2.02M |
| 340 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 158.78M | 3.13% | 94,720 | - |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 155.46M | 2.34% | 424,134 | 225.00K |
| 342 | CGTX | Cognition Therapeutics, Inc. | 149.91M | -0.30% | 571,874 | - |
| 343 | SPRB | Spruce Biosciences, Inc. | 149.64M | -0.60% | 6,039 | 697.00K |
| 344 | TLSA | Tiziana Life Sciences Ltd | 148.70M | - | 20,555 | - |
| 345 | ADCT | ADC Therapeutics SA | 146.91M | 5.96% | 280,269 | 79.18M |
| 346 | ACOG | Alpha Cognition Inc. | 146.32M | -0.59% | 1,872 | 10.83M |
| 347 | ENLV | Enlivex Ltd. | 144.27M | -3.93% | 70,201 | - |
| 348 | MOLN | Molecular Partners AG | 141.09M | 0.51% | 13,320 | 856.30K |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 140.80M | -0.26% | 131,634 | 2.29M |
| 350 | PYXS | Pyxis Oncology, Inc. | 137.48M | 1.88% | 41,000 | 13.86M |
| 351 | PEPG | PepGen Inc. | 132.11M | 4.37% | 89,239 | - |
| 352 | ALDX | Aldeyra Therapeutics, Inc. | 132.10M | 6.83% | 870,262 | - |
| 353 | GUTS | Fractyl Health, Inc. | 132.03M | -4.23% | 139,871 | 3.00K |
| 354 | NTHI | NeOnc Technologies Holdings, Inc. | 131.64M | 1.76% | 3,394 | 39.99K |
| 355 | AGEN | Agenus Inc. | 130.97M | 3.45% | 53,540 | 123.87M |
| 356 | GNLX | Genelux Corporation | 130.12M | 0.34% | 21,219 | 8.00K |
| 357 | SPRO | Spero Therapeutics, Inc. | 128.54M | 0.45% | 216,874 | 61.19M |
| 358 | COYA | Coya Therapeutics, Inc. | 126.90M | 2.27% | 35,655 | 7.94M |
| 359 | CNTB | Connect Biopharma Holdings Limited | 123.42M | -1.50% | 45,822 | 233.00K |
| 360 | MENS | Jyong Biotech Ltd. | 121.74M | 3.14% | 35,093 | - |
| 361 | CUE | Cue Biopharma, Inc. | 120.12M | -3.38% | 17,461 | 32.73M |
| 362 | PLYX | Polaryx Therapeutics, Inc. | 119.31M | 4.56% | 26,944 | - |
| 363 | ENGN | enGene Therapeutics Inc. | 115.22M | 1.78% | 125,855 | - |
| 364 | ONCY | Oncolytics Biotech Inc. | 112.84M | 3.07% | 166,856 | - |
| 365 | ALPS | Alps Group Inc | 108.14M | -3.86% | 18,101 | 3.74M |
| 366 | FBIO | Fortress Biotech, Inc. | 105.64M | 3.25% | 248,529 | 66.16M |
| 367 | CBUS | Cibus, Inc. | 104.57M | 5.38% | 11,463 | 4.29M |
| 368 | KLRS | Kalaris Therapeutics, Inc. | 104.09M | -0.57% | 1,158 | - |
| 369 | PTHS | Pelthos Therapeutics Inc. | 101.77M | - | 10 | 27.70M |
| 370 | VANI | Vivani Medical, Inc. | 101.33M | 3.98% | 53,073 | - |
| 371 | ATRA | Atara Biotherapeutics, Inc. | 100.73M | 5.37% | 20,648 | 23.14M |
| 372 | VRCA | Verrica Pharmaceuticals Inc. | 99.47M | 2.66% | 4,265 | 37.16M |
| 373 | PYPD | PolyPid Ltd. | 97.79M | -0.58% | 84,856 | - |
| 374 | SEER | Seer, Inc. | 97.59M | 0.85% | 7,601 | 15.17M |
| 375 | RANI | Rani Therapeutics Holdings, Inc. | 97.33M | 1.68% | 185,408 | 3.17M |
| 376 | ANIX | Anixa Biosciences, Inc. | 96.80M | 2.71% | 18,415 | - |
| 377 | BDTX | Black Diamond Therapeutics, Inc. | 95.69M | 3.73% | 265,104 | 70.00M |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 94.61M | 3.60% | 235,279 | 65.34K |
| 379 | RNTX | Rein Therapeutics Inc. | 92.63M | 10.14% | 127,112 | - |
| 380 | PMN | ProMIS Neurosciences, Inc. | 92.56M | -3.36% | 186 | - |
| 381 | BMEA | Biomea Fusion, Inc. | 92.54M | 4.07% | 135,818 | - |
| 382 | AARD | Aardvark Therapeutics, Inc. | 91.52M | 2.82% | 13,382 | - |
| 383 | NRXS | NeurAxis, Inc. | 90.03M | 1.54% | 22,471 | 4.28M |
| 384 | CRDF | Cardiff Oncology, Inc. | 89.91M | 1.15% | 148,460 | 525.00K |
| 385 | TELO | Telomir Pharmaceuticals, Inc. | 88.72M | 0.78% | 8,848 | - |
| 386 | ACET | Adicet Bio, Inc. | 88.10M | 1.94% | 6,224 | - |
| 387 | ICCC | ImmuCell Corporation | 87.93M | -0.26% | 4,130 | 29.93M |
| 388 | IBIO | iBio, Inc. | 86.19M | -0.29% | 61,719 | 300.00K |
| 389 | VRXA | Veraxa Biotech AG | 85.74M | -17.87% | 184,183 | - |
| 390 | CSBR | Champions Oncology, Inc. | 85.62M | -1.35% | 2,557 | 57.95M |
| 391 | ATHE | Alterity Therapeutics Limited | 85.38M | 1.01% | 3,337 | 4.43M |
| 392 | MAIA | MAIA Biotechnology, Inc. | 84.82M | 1.09% | 55,620 | - |
| 393 | RLYB | Rallybio Corporation | 84.00M | -0.47% | 5,610 | 858.00K |
| 394 | OKYO | OKYO Pharma Limited | 83.97M | 1.91% | 30,294 | - |
| 395 | LIXT | Lixte Biotechnology Holdings, Inc. | 83.18M | -4.28% | 25,761 | - |
| 396 | GOSS | Gossamer Bio, Inc. | 82.13M | 2.31% | 1,939,502 | 55.54M |
| 397 | OSTX | OS Therapies Incorporated | 81.95M | 1.10% | 104,295 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 80.62M | 2.16% | 111,173 | - |
| 399 | HRTX | Heron Therapeutics, Inc. | 80.07M | -1.31% | 723,176 | 150.71M |
| 400 | ELTX | Elicio Therapeutics, Inc. | 79.29M | 4.11% | 544,297 | - |
| 401 | ENTX | Entera Bio Ltd. | 78.27M | 7.43% | 1,012,780 | 42.00K |
| 402 | LONA | LeonaBio, Inc. | 76.89M | -1.03% | 1,941 | - |
| 403 | ANVS | Annovis Bio, Inc. | 75.94M | 0.85% | 199,795 | - |
| 404 | HYFT | MindWalk Holdings Corp. | 73.51M | -1.33% | 29,091 | 20.70M |
| 405 | PLRX | Pliant Therapeutics, Inc. | 72.14M | 0.43% | 61,257 | - |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 70.62M | 4.43% | 53,625 | - |
| 407 | XBIT | XBiotech Inc. | 70.43M | - | 278 | - |
| 408 | EXOZ | eXoZymes, Inc. | 68.64M | -1.03% | 1,559 | -700.00 |
| 409 | MCRB | Seres Therapeutics, Inc. | 68.17M | 6.67% | 22,393 | 1.15M |
| 410 | IMA | ImageneBio, Inc. | 67.79M | 0.33% | 486 | 800.00K |
| 411 | BYSI | BeyondSpring Inc. | 66.41M | - | 1,242 | 1.88M |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 65.60M | 7.89% | 187,663 | - |
| 413 | CING | Cingulate Inc. | 65.58M | - | 51,654 | - |
| 414 | MNOV | MediciNova, Inc. | 64.62M | 0.98% | 70,635 | 596.64K |
| 415 | KALA | KALA BIO, Inc. | 64.23M | -2.40% | 19,455 | - |
| 416 | EDSA | Edesa Biotech, Inc. | 63.76M | 5.29% | 34,223 | - |
| 417 | TCRX | TScan Therapeutics, Inc. | 61.59M | 8.95% | 252,717 | 9.14M |
| 418 | INKT | MiNK Therapeutics, Inc. | 61.30M | 0.45% | 2,878 | - |
| 419 | FLNA | Filana Therapeutics, Inc. | 60.87M | 1.61% | 39,643 | - |
| 420 | CNTX | Context Therapeutics Inc. | 60.16M | 3.95% | 962,183 | - |
| 421 | IBO | Impact BioMedical Inc. | 56.23M | -1.99% | 15,005 | 39.00K |
| 422 | XLO | Xilio Therapeutics, Inc. | 54.50M | 1.90% | 5,531 | 53.48M |
| 423 | PDSB | PDS Biotechnology Corporation | 54.14M | 3.05% | 122,544 | - |
| 424 | IMMP | Immutep Limited | 53.72M | 1.03% | 33,107 | 5.28M |
| 425 | HYPD | Hyperion DeFi, Inc. | 53.42M | 1.35% | 110,669 | 1.04M |
| 426 | MREO | Mereo BioPharma Group plc | 53.01M | 2.18% | 147,170 | 500.00K |
| 427 | BOLD | Boundless Bio, Inc. | 52.56M | 67.14% | 36,931,803 | - |
| 428 | DWTX | Dogwood Therapeutics, Inc. | 51.45M | -0.65% | 2,021 | - |
| 429 | TIL | Instil Bio, Inc. | 51.27M | - | 194 | - |
| 430 | ELOX | Eloxx Pharmaceuticals, Inc. | 50.94M | -9.14% | 5,672 | - |
| 431 | RADX | Radiopharm Theranostics Limited | 49.69M | -0.23% | 1,788 | 10.86M |
| 432 | LTRN | Lantern Pharma Inc. | 49.06M | -0.52% | 24,085 | - |
| 433 | ACTU | Actuate Therapeutics, Inc. | 48.21M | 0.25% | 14,669 | - |
| 434 | VERU | Veru Inc. | 48.15M | 1.35% | 69,716 | 16.89M |
| 435 | ATYR | aTyr Pharma, Inc. | 48.05M | 4.21% | 215,063 | 190.00K |
| 436 | MGX | Metagenomi Therapeutics, Inc. | 46.12M | 2.94% | 14,315 | 22.33M |
| 437 | GNTA | Genenta Science S.p.A. | 44.82M | -1.04% | 165,060 | - |
| 438 | APLM | Apollomics, Inc. | 42.65M | -14.94% | 12,910 | 8.84M |
| 439 | TVGN | Tevogen Bio Holdings Inc. | 41.41M | 0.71% | 667 | - |
| 440 | RNXT | RenovoRx, Inc. | 41.35M | 0.73% | 41,762 | 1.49M |
| 441 | ESLA | Estrella Immunopharma, Inc. | 40.88M | 1.69% | 15,730 | - |
| 442 | INMB | INmune Bio Inc. | 39.35M | 3.50% | 64,148 | 50.00K |
| 443 | NTRB | Nutriband Inc. | 39.14M | 3.54% | 4,367 | 1.80M |
| 444 | GRCE | Grace Therapeutics, Inc. | 38.89M | 5.75% | 64,446 | - |
| 445 | FTH | Faeth Therapeutics, Inc. | 36.23M | 16.43% | 49,592 | - |
| 446 | ALGS | Aligos Therapeutics, Inc. | 36.21M | 2.83% | 26,839 | 4.71M |
| 447 | CRVO | CervoMed Inc. | 35.65M | -6.78% | 666,314 | 2.09M |
| 448 | GRDX | GridAI Technologies Corp. | 33.93M | 4.94% | 2,184 | - |
| 449 | ABVC | ABVC BioPharma, Inc. | 32.81M | -1.65% | 21,179 | 797.92K |
| 450 | ATNM | Actinium Pharmaceuticals, Inc. | 32.32M | - | 8,300 | 90.00K |
| 451 | LSTA | Lisata Therapeutics, Inc. | 32.10M | 1.59% | 2,583 | 170.00K |
| 452 | DARE | Daré Bioscience, Inc. | 31.76M | 3.41% | 18,282 | 1.16M |
| 453 | SNTI | Senti Biosciences Holdings, Inc. | 30.51M | 0.51% | 11,553 | 38.00K |
| 454 | NNVC | NanoViricides, Inc. | 30.07M | - | 85,094 | - |
| 455 | EVAX | Evaxion A/S | 30.02M | 5.26% | 3,315 | 7.53M |
| 456 | LITS | Lite Strategy, Inc. | 29.94M | -1.53% | 54,842 | - |
| 457 | SER | Serina Therapeutics, Inc. | 29.70M | 4.76% | 12,149 | 130.00K |
| 458 | DYAI | Dyadic International, Inc. | 29.37M | 2.68% | 27,134 | 3.81M |
| 459 | PSTV | Plus Therapeutics, Inc. | 28.91M | 5.53% | 46,594 | 5.18M |
| 460 | BRNS | Barinthus Biotherapeutics plc | 28.51M | - | 11 | 14.97M |
| 461 | KYNB | Kyntra Bio, Inc. | 27.85M | - | 252 | 7.44M |
| 462 | VTGN | Vistagen Therapeutics, Inc. | 27.05M | 3.02% | 283,376 | 1.27M |
| 463 | IGC | IGC Pharma, Inc. | 26.70M | 1.39% | 197,287 | 1.11M |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 26.61M | -4.60% | 25,571 | - |
| 465 | BCTX | BriaCell Therapeutics Corp. | 26.17M | 5.02% | 34,664 | - |
| 466 | PLRZ | Polyrizon Ltd. | 25.44M | 3.03% | 8,365 | - |
| 467 | TVRD | Tvardi Therapeutics, Inc. | 25.33M | 0.75% | 2,262 | - |
| 468 | LGVN | Longeveron Inc. | 24.92M | -0.04% | 32,150 | 1.22M |
| 469 | SKYE | Skye Bioscience, Inc. | 24.49M | -1.69% | 85,612 | - |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 24.00M | - | 15,756 | -13.27K |
| 471 | QNTM | Quantum BioPharma Ltd. | 23.40M | -0.71% | 27,573 | - |
| 472 | MRKR | Marker Therapeutics, Inc. | 22.84M | - | 1,536 | 3.55M |
| 473 | PLUR | Pluri Inc. | 21.79M | - | 6,546 | 1.08M |
| 474 | ALLR | Allarity Therapeutics, Inc. | 21.64M | - | 26,506 | 345.00K |
| 475 | LPCN | Lipocine Inc. | 21.52M | 13.97% | 69,060 | 2.00M |
| 476 | VYNE | VYNE Therapeutics Inc. | 21.50M | -0.74% | 6,074 | 454.00K |
| 477 | LNAI | Lunai Bioworks Inc. | 20.63M | 9.64% | 78,797 | 20.94K |
| 478 | CLRB | Cellectar Biosciences, Inc. | 20.46M | -0.39% | 4,904 | - |
| 479 | PTN | Palatin Technologies, Inc. | 20.18M | -0.34% | 1,277 | 12.88M |
| 480 | CELU | Celularity Inc. | 19.83M | -9.64% | 29,615 | 26.55M |
| 481 | TPST | Tempest Therapeutics, Inc. | 18.37M | -0.76% | 16,183 | - |
| 482 | HOWL | Werewolf Therapeutics, Inc. | 18.34M | 1.97% | 192,025 | 1.14M |
| 483 | PASG | Passage Bio, Inc. | 18.19M | -0.87% | 14,724 | - |
| 484 | KTTA | Pasithea Therapeutics Corp. | 18.11M | 0.58% | 6,419 | - |
| 485 | CVM | CEL-SCI Corporation | 18.00M | 1.99% | 76,199 | - |
| 486 | XCUR | Exicure, Inc. | 17.97M | 2.92% | 10,510 | 500.00K |
| 487 | NCEL | NewcelX Ltd. | 17.94M | -4.52% | 350 | - |
| 488 | GTBP | GT Biopharma, Inc. | 17.85M | 0.90% | 454,020 | - |
| 489 | MLEC | Moolec Science SA | 17.50M | 5.31% | 11,793 | 7.83M |
| 490 | AEON | AEON Biopharma, Inc. | 16.74M | -3.49% | 3,278 | - |
| 491 | ATOS | Atossa Therapeutics, Inc. | 16.71M | 6.01% | 93,526 | - |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 16.20M | 3.62% | 31,504 | 5.61M |
| 493 | QNCX | Quince Therapeutics, Inc. | 16.11M | 6.55% | 195,353 | - |
| 494 | BIVI | BioVie Inc. | 14.93M | 2.06% | 64,434 | - |
| 495 | CRIS | Curis, Inc. | 14.89M | -12.97% | 285,026 | 7.06M |
| 496 | LEXX | Lexaria Bioscience Corp. | 14.75M | 2.10% | 2,207 | 368.00K |
| 497 | HIND | Vyome Holdings, Inc. | 14.74M | -3.23% | 16,192 | 152.72K |
| 498 | INAB | IN8bio, Inc. | 14.38M | - | 4,501 | - |
| 499 | COCP | Cocrystal Pharma, Inc. | 14.34M | 4.04% | 16,548 | 225.00K |
| 500 | MBRX | Moleculin Biotech, Inc. | 14.19M | -14.74% | 10,191,182 | - |